Login to Your Account

Pharma: other news to note

Friday, March 21, 2014
Eisai Co. Ltd., of Woodcliff Lake, N.J., said it entered a collaboration with nonprofit organization Liverpool School of Tropical Medicine (LSTM) and the University of Liverpool to identify new drugs against lymphatic filariasis and onchocerciasis (river blindness), both major types of the parasitic tropical disease filariasis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription